Arbutus Biopharma Corporation ABUS Change in Other Liabilities
Change in Other Liabilities at other companies
Other financials
Where this comes from
Reported directly by Arbutus Biopharma Corporation in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOtherOperatingLiabilities.
The official record: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Arbutus Biopharma Corporation's change in other liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Arbutus Biopharma Corporation's change in other liabilities?
- Arbutus Biopharma Corporation (ABUS) reported change in other liabilities of -$105K in Q1 2026.
- How has Arbutus Biopharma Corporation's change in other liabilities changed year-over-year?
- Arbutus Biopharma Corporation's change in other liabilities decreased by 1.0% year-over-year, from -$104K to -$105K.
- What is the long-term trend for Arbutus Biopharma Corporation's change in other liabilities?
- Over 4 years (2021 to 2025), Arbutus Biopharma Corporation's change in other liabilities has grown at a 10.5% compound annual growth rate (CAGR), from -$374K to -$557K.
- What does change in other liabilities mean?
- Change in miscellaneous liabilities affecting operating cash flow.